Design and Synthesis of a Mitochondrial‐Targeted JNK Inhibitor and Its Protective Effect on Parkinson's Disease Phenotypes
ChemBioChem · 2023
DOI: 10.1002/cbic.202200748 ↗Kurz gefasst
Fachartikel in der Zeitschrift ChemBioChem, 2023. Verfasst von Zhiqiang Zhou und 9 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Flexible Electronics (KLOFE) & Institute of Advanced Materials (IAM), Nanjing Tech University, 5 Xinmofan Road, Nanjing, 211816, P.…. Hauptthemen laut MEDLINE: Parkinson Disease. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 54 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Jiangsu Province, Natural Science Foundation of Shanxi Province.
Abstract (Originalsprache)
C‐Jun N‐terminal kinase (JNK) is a key mediator involved in a variety of physiological processes. JNK activation is regulated in a complex manner by upstream kinases and phosphatases, and plays an important role in physiological processes such as the immune response and neuronal function. Therefore, JNK has become a therapeutic target for neurodegenerative diseases, ankylosing spondylitis, psoriasis, arthritis and other diseases. Inhibition of JNK activation in mitochondria holds great potential for Parkinson's disease (PD) therapy. However, no specific mitochondrial‐targeted JNK inhibitor has been reported. We have developed a mitochondrial‐targeted JNK inhibitor, P2 , by linking a mitochondrial‐specific cell‐penetrating peptide to SP600125 ( SP ), a commercialized specific inhibitor of JNK. We found that P2 specifically inhibited mitochondrial JNK phosphorylation instead of nuclear JNK signaling. Further studies showed that P2 effectively rescued PD phenotypes both in vitro and in vivo, thus indicating that it is a potential therapeutic for PD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Flexible Electronics (KLOFE) & Institute of Advanced Materials (IAM), Nanjing Tech University, 5 Xinmofan Road, Nanjing, 211816, P. R. China.
- The Institute of Flexible Electronics (IFE, Future Technologies), Xiamen University, 422 Siming South Road, Xiamen, 361005, P. R. China.
- Key Laboratory of Bioorganic Synthesis of Zhejiang Province, College of Biotechnology and Bioengineering, Zhejiang University of Technology, 18 Chaowang Road, Hangzhou, 310014, P. R. China.
- School of Basic Medical Sciences, Shanxi Medical University, 56 Xinjian South Road, Taiyuan, 310003, P. R. China.
- Lee Kong Chian School of Medicine, Nanyang Technological University, 11 Mandalay Road, 302238, Singapore, Singapore.
ORCID-Profile: Lin Li
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Jiangsu Province
- Natural Science Foundation of Shanxi Province
Zitieren
APA
Zhou, Z., Zhang, D., Du, F., An, W., Ge, J., Yu, C., Yang, N., Zhang, C., Lim, K., & Li, L. (2023). Design and Synthesis of a Mitochondrial‐Targeted JNK Inhibitor and Its Protective Effect on Parkinson's Disease Phenotypes. ChemBioChem. https://doi.org/10.1002/cbic.202200748
Vancouver
Zhou Z, Zhang D, Du F, An W, Ge J, Yu C, et al. Design and Synthesis of a Mitochondrial‐Targeted JNK Inhibitor and Its Protective Effect on Parkinson's Disease Phenotypes. ChemBioChem. 2023. doi:10.1002/cbic.202200748
BibTeX
@article{Zhou2023,
author = {Zhou, Zhiqiang and Zhang, Duoteng and Du, Fangning and An, Weizhen and Ge, Jingyan and Yu, Changmin and Yang, Naidi and Zhang, Chengwu and Lim, Kahleong and Li, Lin},
title = {Design and Synthesis of a Mitochondrial‐Targeted JNK Inhibitor and Its Protective Effect on Parkinson's Disease Phenotypes},
journal = {ChemBioChem},
year = {2023},
doi = {10.1002/cbic.202200748}
}
EUVIMED